TC
PACB icon

TFS Capital’s Pacific Biosciences PACB Stock Holding History

TFS Capital’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-26,034
Closed -$152K – 1045
2015
Q1 		$152K Buy
26,034
+11,688
+81% +$80.6K 0.01% 823
2014
Q4 		$112K Sell
14,346
-24,637
-63% -$158K 0.01% 901
2014
Q3 		$191K Buy
38,983
+6,904
+22% +$36.1K 0.02% 876
2014
Q2 		$198K Buy
32,079
+893
+3% +$4.47K 0.02% 943
2014
Q1 		$167K Sell
31,186
-344,627
-92% -$2.18M 0.01% 1227
2013
Q4 		$1.97M Sell
375,813
-181,224
-33% -$832K 0.09% 317
2013
Q3 		$3.08M Buy
557,037
+122,840
+28% +$426K 0.14% 196
2013
Q2 		$1.1M Buy
+434,197
New +$1.08M 0.05% 570

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TFS Capital's PACB Position: Q2 2015 in Review

TFS Capital sold out of Pacific Biosciences (PACB) in Q2 2015, closing a stake of 26,034 shares — an estimated $152K sold.

TFS Capital first reported a position in PACB in Q2 2013 and held it in 8 quarters. The position peaked at $3.08M in Q3 2013. 102 funds tracked by Wall St. Rank hold PACB as of Q2 2015.

  • TFS Capital reported no remaining Pacific Biosciences position as of Q2 2015 after selling out during the quarter.
  • TFS Capital sold 26,034 Pacific Biosciences shares in Q2 2015, an estimated $152K.
  • TFS Capital first reported a position in Pacific Biosciences in Q2 2013 and held it in 8 quarters.
  • TFS Capital's Pacific Biosciences position peaked at $3.08M in Q3 2013.
  • 102 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2015.

Based on TFS Capital's 13F filing for Q2 2015, filed 5 Aug 2015.